Regulatory Affairs (RA)
Straight Line experts can support you develop a strategy for your NDS and sNDS.
Our expertise spans from innovator product in niche therapy areas such as rare diseases, oncology, gene therapy, all the way to generics and mainstream treatments.
We are deep expertise in medical device approval submissions and combination products.
1
Regulatory Consulting
-
Regulatory strategy, license applications, post-marketing life cycle, reimbursement and Market Access consulting
-
Agency Meetings management, Pre-ITA, Pre-Submission Appeal and Q meetings
2
Drug Approval Submission
-
Application dossier compilation
-
Product Classification, Request for Designation
-
Clinical Trial Application Guidance and Submissions (ITA and IDE)
3
Risk Management Plan
-
Risk Assessments: Evaluating new product risks in processes, products, and suppliers.
-
Risk Mitigation: Implementing strategies to mitigate identified risks.
Get in Touch
speak to one of our experts today and get a tailored solution for your needs